Education
About Us
Working with TipRanks
Follow Us
Michael Andrew Chambers Insider Profile
18 Followers
Michael Andrew Chambers, Director at Sarepta Therapeutics, holds 294.69K shares in Sarepta Therapeutics (Ticker: SRPT).
Michael Andrew Chambers Sarepta Therapeutics (SRPT)Director
Sarepta Therapeutics (SRPT)
Director
Ranked #60,740 out of 106,131 Corporate Insiders
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
-3.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michael Andrew Chambers's holdings
Insider Roles
Director
Roles that Michael Andrew Chambers holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 14, 2023 - Aug 14, 2024
Return:+18.30%
The most profitable trade made by Michael Andrew Chambers
Michael Andrew Chambers's Trading History
List of latest transactions for each holding click on a transaction to see Michael Andrew Chambers's performance on stock
You May Also Like
Michael Andrew Chambers insider profile FAQ
What is the percentage of profitable transactions made by Michael Andrew Chambers?
The percentage of profitable transactions made by Michael Andrew Chambers is 83%.
What is the average return per transaction made by Michael Andrew Chambers?
The average return per transaction made by Michael Andrew Chambers is -3.60%.
What stocks does Michael Andrew Chambers hold?
Michael Andrew Chambers holds: SRPT stocks.
What was Michael Andrew Chambers’s latest transaction?
Michael Andrew Chambers latest transaction was an Uninformative Buy of ―.
What was Michael Andrew Chambers's most profitable transaction?
Michael Andrew Chambers’s most profitable transaction was an Informative Buy of SRPT stock on August 14, 2023. The return on the trade was 18.30%.
What is Michael Andrew Chambers's role in Sarepta Therapeutics?
Michael Andrew Chambers's role in Sarepta Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.